Literature DB >> 23894152

Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance.

Amelie V Guitart1, Chithra Subramani, Alejandro Armesilla-Diaz, Gillian Smith, Catarina Sepulveda, Deniz Gezer, Milica Vukovic, Karen Dunn, Patrick Pollard, Tessa L Holyoake, Tariq Enver, Peter J Ratcliffe, Kamil R Kranc.   

Abstract

Local hypoxia in hematopoietic stem cell (HSC) niches is thought to regulate HSC functions. Hypoxia-inducible factor-1 (Hif-1) and Hif-2 are key mediators of cellular responses to hypoxia. Although oxygen-regulated α-subunits of Hifs, namely Hif-1α and Hif-2α, are closely related, they play overlapping and also distinct functions in nonhematopoietic tissues. Although Hif-1α-deficient HSCs lose their activity on serial transplantation, the role for Hif-2α in cell-autonomous HSC maintenance remains unknown. Here, we demonstrate that constitutive or inducible hematopoiesis-specific Hif-2α deletion does not affect HSC numbers and steady-state hematopoiesis. Furthermore, using serial transplantations and 5-fluorouracil treatment, we demonstrate that HSCs do not require Hif-2α to self-renew and recover after hematopoietic injury. Finally, we show that Hif-1α deletion has no major impact on steady-state maintenance of Hif-2α-deficient HSCs and their ability to repopulate primary recipients, indicating that Hif-1α expression does not account for normal behavior of Hif-2α-deficient HSCs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23894152     DOI: 10.1182/blood-2013-02-484923

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

Review 1.  Mitochondrial regulation of hematopoietic stem cells.

Authors:  Hans-Willem Snoeck
Journal:  Curr Opin Cell Biol       Date:  2018-01-05       Impact factor: 8.382

2.  Harnessing Hematopoietic Stem Cell Low Intracellular Calcium Improves Their Maintenance In Vitro.

Authors:  Larry L Luchsinger; Alexandros Strikoudis; Nichole M Danzl; Erin C Bush; Michael O Finlayson; Prakash Satwani; Megan Sykes; Masayuki Yazawa; Hans-Willem Snoeck
Journal:  Cell Stem Cell       Date:  2019-06-06       Impact factor: 24.633

3.  The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viability.

Authors:  Bryan L Krock; Tzipora S Eisinger-Mathason; Dionysios N Giannoukos; Jessica E Shay; Mercy Gohil; David S Lee; Michael S Nakazawa; Julie Sesen; Nicolas Skuli; M Celeste Simon
Journal:  Blood       Date:  2015-04-08       Impact factor: 22.113

4.  Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.

Authors:  C E Forristal; A L Brown; F M Helwani; I G Winkler; B Nowlan; V Barbier; R J Powell; G A Engler; S M Diakiw; A C W Zannettino; S Martin; D Pattabiraman; R J D'Andrea; I D Lewis; J P Levesque
Journal:  Leukemia       Date:  2015-04-29       Impact factor: 11.528

5.  Loss of HIF-1α accelerates murine FLT-3(ITD)-induced myeloproliferative neoplasia.

Authors:  T Velasco-Hernandez; D Tornero; J Cammenga
Journal:  Leukemia       Date:  2015-06-24       Impact factor: 11.528

Review 6.  Hypoxia-inducible factors link iron homeostasis and erythropoiesis.

Authors:  Yatrik M Shah; Liwei Xie
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

Review 7.  Hypoxia regulates the hematopoietic stem cell niche.

Authors:  Takayuki Morikawa; Keiyo Takubo
Journal:  Pflugers Arch       Date:  2015-10-21       Impact factor: 3.657

Review 8.  Hematopoietic Stem Cell Metabolism during Development and Aging.

Authors:  Ayako Nakamura-Ishizu; Keisuke Ito; Toshio Suda
Journal:  Dev Cell       Date:  2020-07-20       Impact factor: 12.270

Review 9.  Hypoxia and HIFs in regulating the development of the hematopoietic system.

Authors:  Parisa Imanirad; Elaine Dzierzak
Journal:  Blood Cells Mol Dis       Date:  2013-10-05       Impact factor: 3.039

Review 10.  Biology of the bone marrow microenvironment and myelodysplastic syndromes.

Authors:  Erinn B Rankin; Anupama Narla; Joseph K Park; Shuo Lin; Kathleen M Sakamoto
Journal:  Mol Genet Metab       Date:  2015-07-20       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.